Uric Acid
Uric Acid
Uric Acid
ABSTRACT
Objectives: To compare the level of uric acid in diabetic and non-diabetic populations of District Nowshera
Methods: This Cross-sectional observational study was conducted in Department of Biochemistry Nowshera Medical
College & Qazi Hussain Ahmed Medical Complex Nowshera from January-December 2018. Both male and female pa-
tients from 24-65 years were included in this study. Nearly one hundred samples were collected from selected patients
for further investigation of serum Uric Acid and Blood glucose level.
Results: The number of cases having no diabetes were 77% out of which 59% of the patient had normal uric acid
while 18% of the patient had abnormal uric acid. The number of cases having diabetes was 23% out of which 17% of
the patients had normal uric acid while 6% of the patients had abnormal uric acid.
Conclusion: 6 percent Diabetics patients of Nowshera District had abnormal uric acid while 18 percent of Non-Diabetics
patients had abnormal uric acid in our present study.
Key words: Hyperuricemia, gout, Hyperglycemia ,Hypoglycemia ,Diabetic ketoacidosis
CONCLUSION
According to our study regarding the history
of Diabetic patients, 77% were non-diabetic patients,
and 23% were diabetic out of the total 100 patients as
shown in Table 4. According to the cross tabulation,
the number of cases having no diabetes were 77% out
of which 59% of the patient had normal uric acid while
18% of the patient had abnormal uric acid.
REFERENCES
1. McCrudden, Francis H. (2008). Uric Acid. BiblioBa-
zaar.
2. Scheele, V. Q. Examen Chemicum Calculi Urinari,
Opuscula, 1776, 2, 73.
3. Behrend, Robert (1925). “Zur Geschichte der
Harnsäuresynthesen”. Justus Liebigs Annalen
der Chemie (in German) (Weinheim, Baden-Würt-
temberg, Germany: WILEY-VCH Verlag GmbH
& Co. KGaA) 441 (1): 215–216. doi:10.1002/
jlac.19254410114. Retrieved June 13, 2013.
4. R. S. Gray, W. J. Irvine, and B. F. Clarke, “Screening
for thyroid dysfunction in diabetics,” British medical
plays a dual role, both as a prooxidant and as an
journal, vol. 2, no. 6202, p. 1439, 1979.
antioxidant9,10. Type 2 DM is associated with oxidative
stress and increased free radical formation11. It is the 5. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan
hyperglycemia which generates free radicals and also M (July 1993). “Uric acid metabolism and tubular
9. Javier Nieto FA, Iribarren C, Gross D, Comstock W, 16. Kanuchi M et al., Hypouricemia in hospitalized dia-
Cutler G. The uric acid and the serum antioxidant betics patients. J. Nara. Med. Ass. 1997;48,268-72.
capacity: a reaction to atherosclero¬sis? Athero- 17. Bonsnes RW, Dana ES. On the increased uric
sclerosis.2000; 148:131–39. acid clearance follow¬ing the intravenous infu-
10. Bagnati M, Cristina P, Cristiana CAU, Roberta B, sion of a hypertonic glucose solution. J Clin In-
Emanuele A, Giorgio B. When and why a water-sol- vest.1946;25:386-88.
uble antioxidant becomes pro-oxidant during a 18. Martín NE, García NV. Hypouricemia and the tubular
copper-induced, low-density lipoprotein oxidation : transport of uric acid. Nefrologia. 2011; 31(1):44-50.
a study which was done by using uric acid. Biochem
J. 1999; 340: 143-52. 19. Shichiri M, Iwamoto H, Shiigai T. Diabetic renal
hypouricemia. Arch Intern Med1987:147(2):225-28
11. Strasak AM, Rapp K, Hilbe W, Oberaigner W, Rut-
tmann E, Con¬cin H. The role of serum uric acid